Whether leading, attending, or hosting, we stay busy and in the loop.




Edinburgh International Conference Centre, Edinburgh
December 7-9, 2022

The DDL Conference is the Premier International Conference covering all aspects of respiratory drug delivery. DDL attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts. DDL offers the opportunity for lectures, posters and exhibitions to be closely located thereby enhancing interactions and networking opportunities for attendees, presenters and exhibitors. DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists.

Click here to register.


Whether making headlines for our work—or creating info you need now—you can find it here.

Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO

Kindeva Drug Delivery and Meridian Medical Technologies To Combine

Kindeva Drug Delivery announces collaboration with the Temple University School of Pharmacy

Nutriband with Kindeva Drug Delivery demonstrate enhanced abuse-deterrent characteristics for Aversa™ Fentanyl

Kindeva Drug Delivery Acquisition of iPharma Labs Inc. Completed

Kindeva Drug Delivery Announces Collaboration with Synopsys

Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products

Kindeva Drug Delivery to Acquire iPharma Labs Inc.

Virpax Pharmaceuticals Selects Kindeva Drug Delivery as Development Partner for Diclofenac pMDI Commercialization

Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits

Viatris Inc. Announces Receipt of the First FDA Approval for Generic Version of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in Partnership with Kindeva

Kindeva Drug Delivery to Manufacture New, Greener Inhalers at UK Manufacturing Site to Help Cut Carbon Emissions

Kindeva Welcomes Mike Ratigan to the Leadership Team

IPAC-RS Welcomes Kindeva’s Mike Needham to the Board

Nutriband Inc. and Kindeva Drug Delivery sign feasibility agreement to develop AVERSA™ Fentanyl, an abuse deterrent fentanyl patch

Steve Fuechtmann Joins Kindeva Drug Delivery as CFO

Kindeva Drug Delivery commits to sustainable inhaler production with significant new manufacturing investment

Drug Delivery Veteran, Raj Khankari, joins Kindeva Drug Delivery

Accelerating sustainable healthcare product development.

The Medical Alley Association Welcomes Kindeva Drug Delivery CEO Aaron Mann to Board of Directors

Kindeva Drug Delivery Announces Collaboration with Monash University to Study Sustainable Propellants

Kindeva Drug Delivery Announces Knowledge Transfer Partnership with Loughborough University to Study Sustainable Propellants

Kindeva Appoints Greg Sargen to Board of Directors

Kindeva Drug Delivery and Cambridge Healthcare Innovations Limited to Collaborate on Development of Novel Dry-Powder Inhaler Product

Kindeva seals deal to expand operations at Charnwood Campus

Viatris Inc. and Kindeva Drug Delivery Announce FDA Tentative Approval of the First Abbreviated New Drug Application Generic Version of Symbicort® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol

Kindeva Appoints Shawn Cavanagh to Board of Directors

Kindeva and BOL Pharma Sign Agreement for Development of Inhaled Cannabinoid Products

Kindeva Drug Delivery Celebrates Breaking Ground for New Headquarters

Q&A with Kindeva Drug Delivery: Putting patients at the centre of drug development

Planning for Brexit : A case study on the strategic role CDMOs can play for their customers

Kindeva experts speak with ODD about future innovation in sustainable inhalation drug delivery

world's first modern asthma inhaler

Kindeva scientists talk to BBC Witness History about the world's first modern asthma inhaler

Kindeva logo

Kindeva experts talk to PMPS about the lasting impact COVID-19 will have on drug delivery

Product Development

Show, don't tell: how CDMO quality systems affect your product

kindeva lab news and blog

Biotech's mirrored universe: predictive engineering and digital twinning

Addressing the challenges of vaccines and intradermal delivery

Woman and child with inhaler

Kindeva: A historic CDMO, reborn

Kindeva talks to the Star Tribune about its launch as an independent company

Kindeva Drug Delivery launches as an independent company

Kindeva Careers

Inventive, curious, and committed to results? We’re hiring.

Explore Job Opportunities